PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $554,000 | +12.8% | 23,180 | +26.6% | 0.00% | 0.0% |
| Q3 2019 | $491,000 | -1.2% | 18,310 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $497,000 | +13.5% | 18,310 | +45.2% | 0.00% | +50.0% |
| Q1 2019 | $438,000 | -59.1% | 12,610 | -55.5% | 0.00% | -66.7% |
| Q2 2018 | $1,070,000 | +14.4% | 28,341 | -1.0% | 0.01% | +20.0% |
| Q1 2018 | $935,000 | +310.1% | 28,631 | +510.3% | 0.01% | +400.0% |
| Q4 2017 | $228,000 | -40.9% | 4,691 | -34.4% | 0.00% | -50.0% |
| Q3 2017 | $386,000 | +67.8% | 7,150 | -26.6% | 0.00% | 0.0% |
| Q2 2016 | $230,000 | -35.4% | 9,745 | -29.0% | 0.00% | -50.0% |
| Q1 2014 | $356,000 | – | 13,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |